Our findings showed that mSEPT9 performed better than other blood markers (CEA, CA19-9, NLR and PLR) for CRC diagnosis, in which patients with CRC in China were distinguished from healthy individuals with a sensitivity of 71.7%, specificity of 88.8%, and AUC of 0.802. Here, CEACAM5 is linked to colorectal carcinoma.